Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Predictive Oncology Inc.

Get SEC filing alerts via email and in your feed for Predictive Oncology Inc.

POAI

Predictive Oncology Inc.

About Predictive Oncology Inc.

Predictive Oncology Inc. leverages artificial intelligence and a proprietary biobank of over 150,000 tumor samples to support cancer drug discovery and development. The company provides AI-driven predictive models, tumor-specific 3D cell culture models, and clinical tumor profiling tests. Its core markets include biopharmaceuticals, diagnostics, and healthcare providers, focusing on improving drug success rates, personalized treatments, and efficient oncology research.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Predictive Oncology Inc.

1
1
Predictive Oncology Inc. Axe Compute Inc. Reports 68% Revenue Decline and Significant Losses in Q1 2026

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
Predictive Oncology Inc. Axe Compute Inc. Reports Revenue Growth to $125,284 but Faces $233.1 Million Net Loss

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
Predictive Oncology Inc. Predictive Oncology Reports $77.7 Million Net Loss and Financial Challenges in Latest 10-Q

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Predictive Oncology Inc. Predictive Oncology Reports Significant Revenue Decline and Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Predictive Oncology Inc. Predictive Oncology Reports Revenue Surge to $110K, Reduces Net Loss in Latest 10-Q Filing

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Predictive Oncology Inc. Predictive Oncology Reports Revenue Decline and Strategic Restructuring for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
Predictive Oncology Inc. Predictive Oncology Reports Significant Revenue Decline and Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments